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ABS TRACT
Objective: The aim of this study was to investigate the cognitive status 
of children with subclinical hypothyroidism (SH) before and after L-thyroxine 
(L-T4) treatment using event-related potentials (ERPs) and neuropsychological 
tests.
Methods: This prospective study was conducted on a series of 20 children 
with mild SH (free T4 normal and thyroid-stimulating hormone level within 
5-10 µIU/L) who underwent clinical and cognitive assessment before L-T4 
treatment and 6 months afterwards. The recordings of ERPs were done at 
the time of diagnosis and after 6 months of euthyroid state. Neuropsychiatric 
tests for attention, perception, close and remote memory were performed on 
all patients and on the control group which consisted of 20 healthy children 
of normal intelligence.
Results: While pretreatment verbal memory (VM) and verbal recall (VR) 
scores of the SH group were significantly lower than those of the control group 
(p=0.004 and 0.012, respectively), no significant differences between the 
post-treatment and control groups were found in these scores after 6 months 
of L-T4 treatment. Post-treatment VM and VR scores were significantly higher 
than the pretreatment scores in the SH group (p=0.008 and p=0.0001). There 
were no significant differences between the pre-and post-treatment values 
of electrophysiological evaluation in N1, P2, P3 latencies or P3 amplitude 
(p>0.05), although there was a significant decrease in N2 latency in the post-
treatment group (p=0.03).
Conclusion: SH affects cognition in children and L-T4 replacement therapy 
leads to normalization of cognitive functions. Neuropsychological tests can 
be used as complementary measures in the evaluation of children with SH. 
Determining the association between ERPs and SH would contribute to the 
comprehensive evaluation of these children.
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Introduction
Thyroid hormones are essential for brain development 
starting from intrauterine life. Their deficiency is associated 
with peripheral and central nervous system dysfunctions 
(1,2). Several studies showed that mental outcome greatly 
improved following the introduction of systematic screening 
for congenital hypothyroidism and initiation of treatment at 
an early age, enabling patients with hypothyroidism to attend 
school and have a normal life (3,4). Cognitive symptoms 
reported in hypothyroidism include lack of initiative, inability 
to concentrate, impaired recall and short-term memory 
deficit (2). Left untreated, longstanding overt hypothyroidism 
can lead to irreversible cognitive impairment. 
Subclinical hypothyroidism (SH) is defined as a state of 
increased serum thyroid-stimulating hormone (TSH) levels 
along with circulating thyroxine (T4) within the population 
reference range (5). SH was reported to occur in 1.7-5.7% 
of children (6,7). There is growing evidence that SH may be 
associated with a risk of cognitive decline.
Event-related potentials (ERPs) are being more and 
more commonly used to evaluate the cognitive functions 
quantitatively in different disease states (8,9). ERPs are those 
potentials of the electroencephalography which are evoked 
by the preparation of or for events and they include an early 
sensory evoked potential and a late (cognitive) response P3 
component. Several authors have suggested that the P3 
wave generated upon applying visual or auditory stimuli can 
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be a useful tool for objectively assessing some cognitive 
functions such as attention and short-term memory (10,11). 
However, to date, there are no published studies on analysis 
of ERPs in children with SH. The objectives of this present 
study were: a) to determine the characteristics of ERPs in 
a series of children diagnosed with SH and compare them 
with those of a control group, b) to identify the changes that 
occur in ERP latency and amplitudes after L-T4 treatment 
and c) to establish the relation between ERPs and the 
cognitive state of children before and after L-T4 treatment.
Methods
Twenty children diagnosed with SH were recruited from 
9-13 years old children who were admitted to the Pediatric 
Endocrinology outpatient clinic of Süleyman Demirel 
University Faculty of Medicine, from May 2012 to January 
2013. The diagnosis of SH was based on the findings 
of a normal free T4 (fT4) level along with a TSH level 
between 5-10 µIU/L. These levels were confirmed with a 
second measurement 4-6 weeks later. The control group 
also consisted of 20 children who presented to the clinic 
for minor illnesses such as common cold, conjunctivitis 
or routine screening. Children who had any systemic 
disease, including thyroiditis, diabetes mellitus, those taking 
medications/iodine-containing drugs and those who had a 
condition known to effect TSH action or thyroid hormones 
secretion (e.g. glucocorticoid therapy) were excluded. The 
study protocols were approved by the institutional review 
board of the University Ethics Committee. Signed informed 
consent and assent forms were obtained from the parents 
and the children.
The diagnosis of SH children was based on the 
medical history, clinical findings and serum levels for 
free triiodothyronine (fT3), fT4 and TSH. Serum levels 
of fT3, fT4, TSH, antithyroglobulin antibody and 
antithyroid peroxidase antibody were measured using 
the electrochemiluminescence immunoassay method by 
Beckman Coulter DxI 800 analyser (Beckman Coulter 
Access kit, Beckman Coulter, Inc. • 250 S. Kraemer Blvd. • 
Brea, CA 92821 USA). The normal reference ranges for fT3, 
fT4 and TSH applied in our study were 1.4-4.2 pg/mL, 0.69-
1.2 ng/dL and 0.5-4.7 mIU/L, respectively.
The patients came from middle class families. Intelligence 
was not evaluated in this study, but all participants were 
reported to show a normal academic performance at school. 
Each participant took part in two sessions that included the 
recording of ERPs and laboratory investigations. Following 
the first session, L-T4 treatment was started at a dose of 
1 µg/kg/day and the dose was titrated individually every 4-6 
weeks until normal TSH values were achieved. The second 
session was conducted 6 months after maintaining the 
euthyroid state.
Auditory P3
The P3 wave was evoked by auditory oddball paradigm 
(12). We recorded auditory potentials after infrequent high-
pitched (2000 Hz, 80 dB nHL, target stimulus) and frequent 
low-pitched (1000 Hz, 70 dB nHL, non-target stimulus) tone 
bursts of 0.1 ms duration (with a 20-ms plateau and a 9.9-
ms rise/fall time). The subjects were seated upright and 
their visual attention was fixed at a marked point on the 
wall in front of them. They had to be cautious to the tone 
presented to both ears through headphones in a random 
sequence with a 20% probability of target stimulus (total 
stimuli, 200 tone bursts). During the test, each subject 
was asked to count only the target tones and to report 
the number at the end of each run. Data were recorded 
from 16 electrodes attached to the scalp according to the 
10-20 International System and referred to linked ears. 
The response to the frequent tone consisted of negative 
(N1) or positive (P2) deflections; the response to the 
infrequent tone was negative (N1), positive (P2), negative 
(N2) or positive (P3) deflections. N1 and P2 latencies were 
identified in response to frequent tones and N2 and P3 in 
response to rare tones. Amplitude was measured as peak 
to peak. 
It is reported that the P3 amplitude is related to the 
updating of working memory content, although its latency 
is related to the speed of stimulus evaluation. Abnormally 
prolonged P3 latencies were demonstrated in dementia, 
depression and Alzheimer’s disease (13,14,15,16,17).
The N2 component is usually observed between 200 
and 400 ms after the stimulus. This ERP should be used for 
measuring various aspects of executive function, including 
go/no-go task. The N2 component is also related to the 
unexpectedness of the stimulus (18). The amplitude of the 
N2 has been reported to vary as a function of conflict and 
the need for cognitive control (19).
N1 wave is reported to reflect a discrimination process 
that is applied to the attended location (20).
Neuropsychological Tests
Neuropsychological tests for attention, perception, close 
and remote (short and long-term) memory were performed 
by evaluating visual memory, visual spatial relationship, 
verbal memory (VM), verbal recall (VR), digit symbol test 
and digit symbol error.
Each neuropsychological test and ERPs were performed 
double-blindly by the same experienced neurologist (MD) 
and interpreted by another neurologist (SD). The room was 
designed to provide a silent environment where the patient 
could focus on the test. 
For the VM test, a short story was read aloud by 
the interviewer (neurologist) putting special emphasis on 
certain words and the subjects were asked to remember 
those words. The VM score is identified as the number of 
words which were remembered.
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For the VR test, a list of 15 words were read aloud 
to the subjects and the number of the words which they 
remember was counted. This procedure is repeated for 
three times and the mean value is recorded as test score.
The digit symbol test was performed in 90 seconds 
during which the subjects were asked to write the symbols 
and numbers under a column. The test score was evaluated 
after 90 seconds and the total number the subjects were able 
to write was accepted as the test score.
Statistical Analysis
The statistical analyses were performed with SPSS for 
Windows, version 15 (SPSS, Chicago, IL, USA). Mean or median 
(min-max) values were used appropriately, as descriptive 
statistics. Differences in the means of variables were tested 
using both parametric and nonparametric tests depending on 
the distribution of the variables. Differences between groups 
were tested using the Mann-Whitney U test or the student’s 
t-test, as appropriate. The correlations among numerical data 
were analyzed by the Spearman’s coefficient (r). Pre- and post-
treatment values were tested by using Wilcoxon test. A p-value 
of less than 0.05 was considered statistically significant.
Results
The characteristics of the study population are shown in 
Table 1. Gender and age of the subjects were similar in the 
SH and the control groups. Although within normal ranges in 
both groups, mean pretreatment fT4 level of the study group 
was lower than that of the control group (p=0.035). Mean 
pretreatment fT3 levels were similar between the two groups. 
Hashimoto’s thyroiditis was detected in 9 of the 20 patients. 
Four of these patients were positive for one antibody and 5 
were positive for both anti-thyroid antibodies. Mean VM and 
VR scores of the SH group were significantly lower than 
those of the control group before L-T4 treatment (p=0.004 
and 0.012, respectively), while visual memory and visual 
spatial relation scores were similar in the two groups.
As expected, pretreatment TSH values in the SH group 
were significantly higher than those of the control group. 
In the SH subjects, an euthyroid state was reached with 
a median L-T4 dose of 0.83 µg/kg/d (0.5-1-5 µg/kg/d) in a 
median duration of 47 days (31-64 days). At the 6th month 
of treatment, mean fT3, fT4 and TSH levels were 3.36±0.47 
pg/mL, 0.86±0.14 ng/dL and 2.58±1.37 mIU/L, respectively. 
There was no statistically significant difference between the 
fT4 values of the control and post-treatment groups.
Visual memory, VM and VR scores significantly improved 
after L-T4 treatment (p=0.008, 0.001 and 0.006, respectively). 
Results of the pre- and post-treatment neuropsychological 
tests are shown in Table 2. The present study revealed 
significant shortening of N2 in SH patients after 6 months 
of euthyroid state as compared to pretreatment values 
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Table 3. Mean latencies of event-related potentials (ERPs) and the 
peak amplitude of P3
Before treatment After treatment p-value
N1 (ms) 112 (92-294) 107 (86-156) 0.202
P2 (ms) 180 (132-398) 182 (140-248) 0.530
N2 (ms) 230 (194-522) 224 (192-306) 0.030
P3 (ms) 330 (264-700) 315 (258-376) 0.373
P3 amp (μV) 23.9 (1-41) 23.4 (3-53) 0.347
Data presented as median (min-max)
Table 1. Characteristics of subclinical hypothyroidism (SH) patients at 
diagnosis and of controls 
Controls Children with 
SH
p-value*
N (girls/boys) 11/9 12/8 0.910**
Age (years) 11.99±1.48 12.27±2.55 0.478
fT3 (pg/mL) 3.28±0.50 3.46±0.53 0.211
fT4 (ng/dL) 0.93±0.16 0.82±0.14 0.035
TSH (mIU/L) 2.07±0.88 6.90±1.29 <0.001
Visual memory score 10.00±2.69 9.55±2.11 0.529
Visual spatial 
relationship score
13 (6-16) 13 (6-15) 0.733***
Verbal memory score 21.85±3.28 18.4±3.54 0.004
Verbal recall score 7.55±1.70 6.25±1.68 0.012
Data are presented as mean ± SD
*Student’s t-test
 **Chi-square test
***Mann-Whitney U test, data are presented as median (min-max)
fT3: free triiodothyronine, fT4: free thyroxine, TSH: thyroid stimulating hormone
Table 2. Neuropsychological test scores of the subclinical 
hypothyroidism patients before and after treatment
Before 
treatment
After 
treatment
p-value*
Visual memory score** 9.55±2.11 11.20±3.01 0.008
Visual spatial 
relationship score**
12.05±3.21 11.85±2.58 0.792
Verbal memory score** 18.40±3.54 22.05±3.69 0.001
Verbal recall score** 6.25±1.68 7.95±1.76 0.006
Digit symbol test score*** 36.5 (9-65) 41.5 (19-57) 0.262
Digit symbol error score*** 1 (0-7) 1 (0-6) 0.477
*Wilcoxon test
**Data presented as mean ± SD
***Data presented as median (min-max)
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(p=0.03) (Table 3). No significant changes in the latencies 
of N1, P2 and P3, nor in the amplitude of P3 waves were 
found. Spearman’s rho correlation was applied to see the 
correlation between the various waves of ERPs and TSH, 
fT3 and fT4 values. There was no significant correlation 
between the TSH values and ERPs or neuropsychiatric 
tests.
Discussion
There is a complete gap of consensus in the field 
of SH. It has long been debated whether this condition 
is a normal variation of thyroid function and if the L-T4 
replacement has any beneficial effect. There are some 
population-based studies in adults which have investigated 
the effect of SH on quality of life, signs and symptoms 
and cognitive function; however, all the reported results 
were controversial (21,22,23,24,25,26,27,28). The effects 
of SH and its treatment on cognitive development is of 
particular interest in children, since it is well known that 
hypothyroidism in young children has effects on brain 
development. There exist some inconsistent data in older 
children on an association between SH and impaired 
neuropsychological development.
It has been reported that “Despite being within the 
normal range, high TSH concentrations are associated with 
a lower cognitive function and low fT4 with attention deficit 
hyperactivity disorder symptoms in healthy preschoolers. 
Statistically significant differences were observed in the 
highest quartiles of TSH” (29). Although this study makes 
us think that SH may influence attention and other cognitive 
functions negatively, another study reported that the mean 
reading and block design scores in SH children were higher 
than those of euthyroid subjects (6). It was hypothesized 
that children with SH were more successful because of 
the decreased activity and lower arousal levels associated 
with the SH state. However, it was noteworthy that the 
cognitive assessment scores of these SH patients were 
much lower than the standardized data among healthy 
adolescents. Although, Wu et al (6) stated that this situation 
might be related with the suboptimal conditions of the test 
environment, the cognitive tests were applied to all subjects 
under the same conditions. Therefore, the assessment 
scores for the different groups would indicate the relative 
levels of cognitive function among the groups and deserve 
consideration (6). As a limitation of the study, the authors 
declared that the number of adolescents with SH was 
rather small (22 in 1327 adolescents). In this present 
study, the number of SH patients was similar to that in the 
aforementioned study, but the neuropsychological tests 
were performed by an experienced neurologist in a room 
which was specially designed for this purpose. The results 
of our double-blind study indicate that VM scores in SH 
subjects were significantly lower than those of the control 
group.
Aijaz et al (30) followed 11 children who had thyroid 
hormone replacement for an average period of 3 months 
and no differences in neuropsychological test scores were 
found before and after treatment. We suggest that the 
inconsistency between the results of the present study 
and those of Aijaz et al (30) could be due to the relatively 
larger sample size and the longer follow-up period of our 
study group. Although the sample size of our study group 
was relatively small, we believe that this kind of longitudinal 
studies contribute much to the debate on the possible 
medical and psychiatric consequences of SH.
Törel Ergür et al (31) investigated the neuropsychological 
effects of SH on 17 Turkish children and reported that the 
children in the SH group, as compared to a control group, 
yielded significantly lower scores on both the Digit Span 
subtest and the subtests, which are sensitive to attention.
In the present study, the visual memory, VM and VR 
scores of the SH patients were significantly lower than 
those of the control group before treatment. However, 
no difference in test scores was noted in the evaluation 
between patients and the control group after six months 
of L-T4 treatment. These results can be interpreted to 
indicate that SH leads to some deterioration of cognitive 
functions and moreover, that treatment with L-T4 causes 
normalization of these scores. In a study on adults, a slight 
but significant improvement of verbal fluency was also 
obtained after 6 months of treatment with L-T4 in a group 
of patients with SH (32).
Verbal encoding appears to be left-lateralized in the 
medial temporal lobe, but its functional neuroanatomy 
can vary (33). The posterior parietal cortex manipulates 
mental images, while the visual cortex receives information 
from the visual field and subcortical regions. Locations are 
preferentially processed in ventral (occipito-temporal) and 
dorsal (occipito-parietal) cortical visual streams (34). Visual 
memory, VM and VR scores significantly improved after 
the L-T4 treatment in our SH subjects. We interpreted 
these results to indicate that, for reasons that are not clear, 
the brain areas mentioned above were more significantly 
affected. Human memory is composed of many connected 
parts. Visual and VM are very active parts of cognitive 
systems and it may be that they are more sensitive to the 
SH state because of their high energy demand.
By using a digit n-back paradigm and a functional 
magnetic resonance imaging, Zhu et al (35) showed that SH 
patients scored significantly lower in the 2-back task than 
the euthyroid subjects and that their working memory was 
impaired especially in frontal executive function. They also 
reported that the load effect of blood oxygen level response 
(which is observed in healthy subjects) in the frontal areas 
was recovered after 6 months of L-T4 treatment in these 
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patients. Yin et al (36) showed that VM and spatial working 
memory of SH patients is impaired with abnormal activity in 
bilateral frontal areas and right posterior parietal lobe. They 
also reported that L-T4 replacement therapy can improve the 
memory impairment and reverse the altered neural activity 
network (36). In another adult study, mild hypothyroidism is 
reported to be related with decreased cerebral blood flow 
in regions mediating attention, memory and visuospatial 
processing (37). According to these data, the mechanism 
of the SH interference with cognition can be related with its 
effects on metabolism and on oxygenation of specific parts 
of the brain. Our results which also showed the impairment 
of VM and visual memory in SH are consistent with 
these conclusions. Significant improvements noted in the 
neuropsychiatric test scores in addition to the decreased 
latency of N2 wave after 6 months of L-T4 treatment 
are considered as further evidence of cognitive decline 
associated with SH.
ERPs are widely accepted as an objective tool for 
evaluating cognitive function. Khedr et al (38) found a 
decrease in amplitude and a significant prolongation of P3 
latency in 26% of hypothyroid patients and suggested that 
neurocognitive function was affected in hypothyroidism. 
Ozata et al (39) found that adult hypothyroid patients had 
longer P3 and N1 wave latencies as compared to controls 
and reported these findings reverted to control values 6 
months after attaining euthyroidism. Relationships have 
been established in patients with Alzheimer’s disease, 
Parkinson’s disease, multiple sclerosis and post-traumatic 
syndrome between P3 onset latency and the patient’s 
level of cognitive functioning (40,41,42). In our study, the 
latencies of the N2 in SH patients significantly decreased 
after 6 months of L-T4 treatment, although no statistically 
significant difference was observed for P3 wave.
Many different components of the ERPs have been 
identified including Nd, P165, NA, N1, P2, N2, P3, P3a, P3b, 
P4 and N (18,43). The N2 component of the ERP is usually 
observed at medial-frontal sites between 200 and 400 ms 
following stimulus presentation on various measures of 
executive function (44,45,46,47,48,49). Executive function 
refers to the deliberate, overall neurocognitive processes 
involved in the regulation of thought, action and emotion and 
it is believed to be a better predictor of achievement than 
IQ (50,51). In an adult study, Nazliel et al (52) reported that 
N2 and P3 latencies in a hypothyroid group were prolonged 
relative to controls and that the differences were statistically 
significant. Although our study group was in the pediatric 
age group and did not have overt hypothyroidism, we 
observed that the N2 component of ERPs was significantly 
improved after 6 months of euthyroid state and we 
concluded that L-T4 therapy in SH has beneficial effects 
on executive function which means better learning skills. 
Thus, this electrophysiological study showed that an optimal 
amount of thyroid hormone is required for normal sensory 
and cognitive processing.
The ERPs in children with SH and their relationship with 
clinical and cognitive status before and after substitution of 
thyroid hormone were also evaluated in this study. There 
was no significant correlation between thyroid hormone 
levels and ERPs before and after L-T4 treatment. This lack 
of correlation may be associated with the TSH level of our 
SH group, a level which was only slightly increased above 
normal. Further studies with larger groups are required in 
this field. Among the limitations of our study, we should 
mention the sample size, because, despite being the most 
extensive series in the literature, the number of our patients 
was also low.
In conclusion, the results of our study indicate that 
children with SH had mild cognitive impairment, identified 
by the prolongation of a latency in ERPs and lower scores 
in visual and VM in neuropsychological tests. The more 
important point is the improvement in these areas following 
treatment with L-T4, which is an evidence of efficacy of 
treatment. This study also shows that some alterations 
can develop in the central nervous system functions in 
SH patients who have a TSH value between 5-10 µIU/L. 
Therefore, neuropsychological tests should be considered 
as complementary measures in assessing the functional 
status of children with SH. An increase in visual and 
VM scores besides the decrease in N2 latency can be 
interpreted as the benefits of the L-T4 treatment in these 
patients.
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